News Tag: Regulatory
-
Ortivus: Year-end report January-December 2024
During the year, we have carried out extensive organisational changes and strengthened our team to support our growth journey. Additionally, we have implemented a new business system to improve financial control and the monitoring of our key metrics.
-
Ortivus will change its listing to Nasdaq First North Growth Market on December 19, 2024
Ortivus AB (publ) (“Ortivus” or the “Company”) has applied for and today received approval for admission to trading on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth Market will be December 19, 2024.
-
Change process continues during third quarter
“During the year, we have made significant progress, which those of you who have followed our reports have surely seen. While we have streamlined our cost structure, we have placed great focus on completing new products that we see as having great potential for the coming years. We are confident that these innovations will meet…
-
Nomination committee in Ortivus AB (publ) ahead of the 2025 annual general meeting
The largest owners in Ortivus AB (publ) have appointed their representatives in the nomination committee ahead of the 2025 annual general meeting, which will be held on May 8, 2025.
